[Comparison of two protocols of febrile urinary tract infection management in children]

Arch Pediatr. 2011 Sep;18(9):955-61. doi: 10.1016/j.arcped.2011.06.005. Epub 2011 Jul 26.
[Article in French]

Abstract

Purpose: To compare two first febrile urinary tract infection (UTI) management protocols with regards to the diagnosis of high-grade vesicoureteral reflux (VUR) and cost.

Methods: This study compared two cohorts of children under 16 years of age, admitted for a first episode of febrile UTI. The first group (in 2005) was managed according to previous recommendations (IV treatment and cystography performed for all children under 3 years of age). The second group (in 2006) was managed according to age and procalcitonin level. High-grade VUR frequency, UTI recurrence, hospitalization rate, and cost were compared between the two cohorts.

Results: A total of 225 children were included in 2005 and 116 in 2006. High-grade VUR was found in 6.2 and 9.5% of the patients in 2005 and 2006, respectively (P=0.274). There was no statistically significant difference in the UTI recurrence rate between the two cohorts (5.3% in 2005 and 8.6% in 2006; P=0.237). The mean cost of an episode of febrile UTI was not significantly different in 2005 and 2006 (€2235 in 2005, €2256 in 2006; P=0.902), but was lower for children older than 6 months in 2006 (€1292 versus €1882 in 2005; P=0.0042).

Conclusion: Our management protocol for a first febrile UTI episode in children based on procalcitonin levels seems to be suitable for the diagnosis of high-grade VUR. The hospitalization rate and the mean cost of management for children older than 6 months of age was significantly reduced in 2006. The management guidelines for a first occurrence of febrile UTI in children should be reconsidered.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Biomarkers / urine
  • Calcitonin / urine
  • Calcitonin Gene-Related Peptide
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Fever / microbiology
  • France
  • Humans
  • Infant
  • Inpatients
  • Length of Stay / economics
  • Male
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Protein Precursors / urine
  • Sensitivity and Specificity
  • Treatment Outcome
  • Urinary Tract Infections / diagnosis
  • Urinary Tract Infections / drug therapy*
  • Urinary Tract Infections / economics
  • Urinary Tract Infections / microbiology*
  • Urinary Tract Infections / urine
  • Vesico-Ureteral Reflux / complications*
  • Vesico-Ureteral Reflux / diagnosis
  • Vesico-Ureteral Reflux / drug therapy*
  • Vesico-Ureteral Reflux / economics
  • Vesico-Ureteral Reflux / urine

Substances

  • Anti-Bacterial Agents
  • Biomarkers
  • CALCA protein, human
  • Protein Precursors
  • Calcitonin
  • Calcitonin Gene-Related Peptide